Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Kleinberg

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Seminars in Radiation Oncology|December 5, 2012
Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcomeLawrence Kleinberg
Patient Preference and Adherence|December 7, 2016
Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapyLawrence Kleinberg
Core Evidence|November 3, 2012
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomideLawrence Kleinberg
Future Oncology (London, England)|June 6, 2007
Evolving management of newly diagnosed brain metastases: expanding role of radiosurgery in lieu of whole brain radiationJana Fox, Lawrence Kleinberg
Chinese Clinical Oncology|March 15, 2023
Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative reviewCarmen Kut, Lawrence Kleinberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Chemoradiation in the management of esophageal cancerLawrence Kleinberg, Arlene A Forastiere
Current Treatment Options in Oncology|June 27, 2015
Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a ConsensusLawrence Kleinberg, Malcolm Brock, Michael Gibson
Neurosurgical Review|November 16, 2013
Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practiceJacob Ruzevick, Lawrence Kleinberg, Daniele Rigamonti
Cancer Investigation|August 17, 2005
Current concepts and controversies in the treatment of parenchymal brain metastases: improved outcomes with aggressive managementGopal K Bajaj, Lawrence Kleinberg, Stephanie Terezakis
Neurosurgery|June 25, 2019
Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of RadiotherapyLawrence Kleinberg, Lindsey Sloan, Stuart Grossman, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Seminars in Radiation Oncology|December 5, 2012
Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcomeLawrence Kleinberg
Patient Preference and Adherence|December 7, 2016
Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapyLawrence Kleinberg
Core Evidence|November 3, 2012
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomideLawrence Kleinberg
Future Oncology (London, England)|June 6, 2007
Evolving management of newly diagnosed brain metastases: expanding role of radiosurgery in lieu of whole brain radiationJana Fox, Lawrence Kleinberg
Chinese Clinical Oncology|March 15, 2023
Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative reviewCarmen Kut, Lawrence Kleinberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Chemoradiation in the management of esophageal cancerLawrence Kleinberg, Arlene A Forastiere
Current Treatment Options in Oncology|June 27, 2015
Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a ConsensusLawrence Kleinberg, Malcolm Brock, Michael Gibson
Neurosurgical Review|November 16, 2013
Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practiceJacob Ruzevick, Lawrence Kleinberg, Daniele Rigamonti
Cancer Investigation|August 17, 2005
Current concepts and controversies in the treatment of parenchymal brain metastases: improved outcomes with aggressive managementGopal K Bajaj, Lawrence Kleinberg, Stephanie Terezakis
Neurosurgery|June 25, 2019
Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of RadiotherapyLawrence Kleinberg, Lindsey Sloan, Stuart Grossman, et al.
Pageof 8